Deactivating variants are less similar; for example, p.His371Tyr two positions N-terminal in CHEK2 in breast cancer [83] and the equivalent N-terminal position p.Leu597Val in BRAF was shown to be activating [84]. This evidence concerns the gene BRAF and breast carcinoma.